![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Anglo Asian Mining Plc | LSE:AAZ | London | Ordinary Share | GB00B0C18177 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.30 | 1.72% | 76.80 | 73.00 | 78.00 | 75.50 | 74.60 | 75.50 | 42,303 | 16:35:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 45.86M | -24.24M | -0.2122 | -3.56 | 86.25M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/7/2020 08:55 | HL will take 50k shares. That almost never happens. They need stock. | ![]() qazwsxedc69 | |
28/7/2020 08:51 | Got to love the shares that share in 10% of the rise and 100% of the fall. | ![]() bonio10000 | |
28/7/2020 08:50 | Not for long our margin just went from $1360 per oz to $1320 per oz, plainly AAZ will be ruined, quick drop the bid. | ![]() lefrene | |
28/7/2020 08:50 | AAZ - can't really blame people for selling before the news with AAZ, LOL, it's always odds on to fall on great news, so I can see why,,, fingers crossed things might just be different this time though :-) we shall see soon enough,,, GLA LTH's Cheers Wan :-) | wanobi | |
28/7/2020 08:35 | 152 to sell. | ![]() ilostthelot | |
28/7/2020 08:21 | get past 160 then next stop old all time high of 172. Looking good here. | ![]() gold finger 1 | |
28/7/2020 08:21 | Thanks Matt. | ![]() cinoib | |
28/7/2020 08:18 | Don't fixate on that, the UT is often deceptive | ![]() mad foetus | |
28/7/2020 08:15 | Well it finished the day on 150/154 and started it at the same price. But as Bazboa said its showing down? Just more psychological games by those dastardly MM's. | ![]() gold finger 1 | |
28/7/2020 08:15 | Looks not for long Bazboa... | ![]() terropol | |
28/7/2020 08:04 | So predictable. Red start. | ![]() bazboa | |
28/7/2020 07:45 | GDP results out not earth shattering but pretty solid if you count that they had shut down for 25 days with c-19. 10m company producing a £5m post tax attributable profit. | ![]() avsome1968 | |
28/7/2020 07:36 | many thanx Bumpa; "The dynamic of a ‘crash’ is a flight to liquidity - always has been, always will" is now engrained into my soul,,, great way to express it.................. Cheers Wan :-) | wanobi | |
28/7/2020 07:33 | LOL, oops, doh Wan,,, many thanx ARP,,, corrected my post LOL Cheers Wan :-) | wanobi | |
28/7/2020 07:31 | POG $1492 !!! Not fallen quite that far. | ![]() arphillips | |
28/7/2020 07:24 | Spot Gold down to 1942 :-),,,, phew LOL,,, happy to see it take a pause :-) Brent at 43.43 Silver at 24.6 :-) likewise LOL Cheers Wan :-) | wanobi | |
28/7/2020 07:23 | PUR results very goodAAU financials out, 7 months after year end but look very good too, share price seems very cheap to me | ![]() mad foetus | |
28/7/2020 07:20 | Good morning all, good luck and good health to you all today :-) Cheers Wan :-) | wanobi | |
28/7/2020 07:12 | Drilling results at PUR | ![]() walter walcarpets | |
28/7/2020 07:08 | CV19 bingo call on ORPH a Phase 1 trail for CV19 has been won, very odd as I was expecting a phase 3 one but hey ho it may move ORPH a little today I hope PLC-Contract-for-COV Awarded Contract from Codagenix Inc. New York USA for COVID-19 Vaccine Trial Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to announce a new contract with Codagenix Inc. ("Codagenix") to conduct a first in human (Phase I) trial evaluating safety and immunogenicity of a single-dose, intranasal SARS-CoV-2 (COVID-19) vaccine candidate in 48 healthy young adult volunteers. Highlights: -- First in human (Phase I) study of CodaVax-COVID, a codon deoptimized SARS-CoV-2 (COVID-19) single-dose, intranasal vaccine candidate -- Vaccine being trialled at hVIVO's state-of-the-art Quarantine Facility in Whitechapel in London -- Phase I study to start in early Autumn with initial data expected by the end of 2020 -- Study will include second dose as surrogate viral challenge at Day 28 hVIVO, part of Open Orphan, will conduct the COVID-19 vaccine trial for Codagenix at its state-of-the-art Quarantine Facility. CodaVax-COVID is a live-attenuated vaccine that replicates very slowly, but contains all SARS-CoV-2 proteins, unlike most other vaccines that only contain the viral spike. This vaccine has the potential to induce broad antibody, cellular and mucosal immunity with a single intranasal dose. hVIVO is currently kicking off the initial steps of this exciting study and are expected to start the trial in the quarantine unit this autumn. This contract reinforces Open Orphan's position as the world leader in the testing of vaccines and antivirals. Cathal Friel, Executive Chairman, Open Orphan, said: "We are proud to be conducting this Phase I study for Codagenix, a leader in their field, as it will help bring a promising vaccine candidate to the public to help combat the COVID-19 pandemic as quickly as possible. hVIVO, with its unique quarantine facility, is one of the few organisations in the world that has now publicly stated that it is working on testing COVID-19 vaccines for efficacy using human challenge model clinical trials. Today's announcement also shows that hVIVO's quarantine facility is uniquely suited to conducting Phase I studies for infectious disease vaccines such as this. Codagenix's expertise in viral design technology, combined with hVIVO's Phase I trial capability, gives us confidence that this trial will be successful and a step forward for the world as it seeks to develop a COVID-19 vaccine to bring the pandemic to a close." Sybil Tasker, MD, MPH, Chief Medical Officer of Codagenix, said: "We are very excited to be collaborating with hVIVO for the first-in-human study of CodaVax-COVID. hVIVO is world-recognized for expertise in evaluation of live viruses in human volunteers. Based on our animal data we expect this vaccine to be effective with a single dose, but will also evaluate a repeat dose to assess potential for boosting and as a model for protection from wildtype challenge. We plan to move quickly from this initial demonstration of safety and immunogenicity in a controlled inpatient setting to larger Phase 2/3 program in conjunction with our partners at Serum Institute of India who are currently scaling up manufacturing to support rapid acceleration of our joint development program." | ![]() pogue | |
28/7/2020 06:40 | No new news in this and good price very out of date but good to see the positive push of the jobs angle | ![]() sparkey_two | |
28/7/2020 03:15 | Well 1980 was a good year for gold lol. | ![]() ramellous | |
28/7/2020 02:24 | Just touched 1980..... | ![]() qazwsxedc69 | |
28/7/2020 01:00 | Can see this bursting through $2000 today the way it’s going tonight. | ![]() ramellous | |
28/7/2020 00:52 | We live in interesting times. Agree with Matt that I'd rather see gold rise in a slow deliberate manner. What we have, however, is the wall of US (and to a certain extent elsewhere) money following the momentum trade - whatever that may be. This seems far more important than any fundamental issue. As I write gold up to $1,964 spot. We're in for a volatile ride - 'cos it can fall as fast as it rises. | ![]() podgyted |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions